Susannah Barbee

Susannah Barbee has a wealth of experience in the biotechnology and pharmaceutical industry, with a strong background in translational biology, immuno-oncology research, and antibody therapeutic programs. Susannah has held various leadership roles in companies such as TRexBio, Five Prime Therapeutics, and Amplimmune. Susannah's expertise lies in driving the development of therapeutics targeting novel tissue Treg-specific targets and identifying cancer immunotherapy targets. Susannah has a Ph.D. in Biology from Caltech and an A.B. in Biochemistry and Molecular Biology from Harvard University.